Paxman AB (PAX) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.014x

Based on the latest financial reports, Paxman AB (PAX) has a cash flow conversion efficiency ratio of -0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.98 Million ≈ $-643.87K USD) by net assets (Skr427.76 Million ≈ $46.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Paxman AB stock valuation for the company's overall valuation and market capitalisation.

Paxman AB - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Paxman AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Paxman AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Paxman AB ranked by their cash flow conversion efficiency. Explore Paxman AB earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Deutsche Konsum REIT AG
XETRA:DKG
-0.008x
QuantumSi Inc
NASDAQ:QSI
-0.128x
Wanhwa Enterprise Co
TW:2701
0.006x
Hope Education Group Co. Ltd
F:HE1
0.049x
Sam Young Chem
KO:003720
0.149x
Feintool International Holding
SW:FTON
0.024x
Bancroft Fund Limited
NYSE MKT:BCV
-0.198x
Vente Unique.com
PA:ALVU
0.416x

Annual Cash Flow Conversion Efficiency for Paxman AB (2017–2024)

The table below shows the annual cash flow conversion efficiency of Paxman AB from 2017 to 2024. View current stock price of Paxman AB for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr163.99 Million
≈ $17.65 Million
Skr39.10 Million
≈ $4.21 Million
0.238x +87.04%
2023-12-31 Skr122.62 Million
≈ $13.20 Million
Skr15.63 Million
≈ $1.68 Million
0.127x +442.03%
2022-12-31 Skr114.20 Million
≈ $12.29 Million
Skr2.69 Million
≈ $289.06K
0.024x +171.39%
2021-12-31 Skr125.75 Million
≈ $13.53 Million
Skr-4.14 Million
≈ $-445.85K
-0.033x +95.77%
2020-12-31 Skr10.89 Million
≈ $1.17 Million
Skr-8.48 Million
≈ $-913.01K
-0.779x -768.59%
2019-12-31 Skr28.36 Million
≈ $3.05 Million
Skr3.31 Million
≈ $355.67K
0.117x +639.81%
2018-12-31 Skr25.39 Million
≈ $2.73 Million
Skr400.00K
≈ $43.05K
0.016x +107.24%
2017-12-31 Skr32.77 Million
≈ $3.53 Million
Skr-7.13 Million
≈ $-767.62K
-0.218x --

About Paxman AB

ST:PAX Sweden Medical Devices
Market Cap
$147.27 Million
Skr1.37 Billion SEK
Market Cap Rank
#17818 Global
#304 in Sweden
Share Price
Skr58.80
Change (1 day)
-0.34%
52-Week Range
Skr43.55 - Skr73.00
All Time High
Skr83.80
About

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of … Read more